Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in OGN — Organon & Co.

CIK 1423053 MIAMI, FL
Back to OGN Full portfolio

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,662,620
-$7,307,735 QoQ
Shares Held
344,359
-82.8% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OGN Over Time

Shares Held

Position Value (USD)

Derivatives in OGN

reported options exposure · as of Jun 30, 2026
CallValue
$2,202,958
CallShares
162,700
PutValue
$4,598,184
PutShares
339,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $3,979,998,649 across 21 Drug Manufacturers - General names. OGN ranks #15 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 945,456 $1,134,008,383
2 ABBV
AbbVie Inc.
 3,169,783 $797,644,194
3 GILD
Gilead Sciences, Inc.
 3,480,444 $439,719,294
4 JNJ
Johnson & Johnson
 1,500,832 $381,166,302
5 AMGN
Amgen Inc
 703,984 $254,926,685
6 MRK
Merck & Co., Inc.
 1,933,667 $248,476,209
7 AZN
Astrazeneca PLC
 970,043 $183,939,553
8 PFE
Pfizer Inc
 6,191,186 $149,083,758

All Filings in OGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,202,958 162,700
2026-06-30 $4,662,620 344,359
2026-06-30 $4,598,184 339,600
2026-03-31 $2,400,193 400,700
2026-03-31 $11,970,355 1,998,390
2026-03-31 $3,180,690 531,000
2025-12-31 $14,791,522 2,062,974
2025-12-31 $2,917,473 406,900
2025-12-31 $2,263,569 315,700
2025-09-30 $4,445,443 416,240
2025-09-30 $4,607,352 431,400
2025-09-30 $3,071,568 287,600
2025-06-30 $4,002,680 413,500
2025-06-30 $4,792,568 495,100
2025-06-30 $52,876,127 5,462,410
2025-03-31 $5,440,806 365,400
2025-03-31 $4,615,900 310,000
2025-03-31 $59,674,161 4,007,667
2024-12-31 $5,251 352
2024-12-31 $2,230,540 149,500
2024-12-31 $6,139,580 411,500
2024-09-30 $55,179,585 2,884,453
2024-09-30 $4,348,249 227,300
2024-09-30 $4,359,727 227,900
2024-06-30 $35,651,774 1,722,308
2024-06-30 $3,848,130 185,900
2024-06-30 $6,588,810 318,300
2024-03-31 $4,549,600 242,000
2024-03-31 $5,987,800 318,500
2024-03-31 $116,127,787 6,177,010
2023-12-31 $4,015,970 278,500
2023-12-31 $5,688,690 394,500
2023-12-31 $60,709,583 4,210,096
2023-09-30 $32,328,260 1,862,227
2023-09-30 $1,433,936 82,600
2023-09-30 $5,473,608 315,300
2023-06-30 $5,824,719 279,900
2023-06-30 $19,598,941 941,804
2023-06-30 $3,483,594 167,400
2023-03-31 $10,140,318 431,136
2023-03-31 $3,949,008 167,900
2023-03-31 $5,534,256 235,300
2022-12-31 $38,594,343 1,381,824
2022-12-31 $3,495,439 125,150
2022-12-31 $8,295,768 297,020
2022-09-30 $23,855,761 1,019,477
2022-09-30 $5,064,696 216,440
2022-09-30 $3,354,858 143,370
2022-06-30 $706,150 20,923
2022-06-30 $6,494,512 192,430

Report a Problem

Category
Description
Email (optional, for follow-up)